文献速递腹部CT

采用快速kVp切换双能CT与低碘对比剂剂量在肝脏增强中的效果:与标准碘剂量单能CT的自身对照比较

Liver enhancement using rapid kVp-switching dual-energy CT with reduced iodine contrast dose compared with single-energy CT with standard iodine dose: an intra-patient comparison.
PubMed 文献 · Abdom Radiol (NY) · 2025-07-17

回顾性比较50 keV虚拟单能双能CT低碘方案(350 mg/kg)与单能CT标准碘方案(525 mg/kg)在原发性肝癌评估中的肝脏强化和肿瘤洗脱表现,50 keV双能CT在门静脉期和延迟期肝脏强化及肿瘤对比均显著高于单能CT,尽管碘剂量降低33%。

要点

  • 50 keV双能CT虚拟单能图像在门静脉期和延迟期肝脏强化及实质对比噪声比均显著高于单能CT。
  • 在77 keV下双能CT的肝脏强化和实质对比噪声比与单能CT相似。
  • 50 keV双能CT在低碘剂量(350 mg/kg)下仍可提高肝细胞癌(LI-RADS 5)的肿瘤强化和对比噪声比。

核心结论

  • 快速kVp切换双能CT在50 keV虚拟单能图像上,尽管碘剂量降低33%,仍可改善门静脉期和延迟期的肝脏及肿瘤对比,支持其用于肝硬化患者。

研究设计与样本

  • 回顾性自身对照研究,连续纳入因原发性肝癌评估而同时接受标准碘剂量单能CT和低碘剂量双能CT的患者77例(平均年龄66±9岁),分析154次CT扫描(2023年2月至2023年10月);比较50 keV虚拟单能双能CT与单能CT图像,并进行77 keV亚组分析。

诊断标准与关键数值

  • 在门静脉期,50 keV双能CT的肝脏相对强化为1.68±0.45,单能CT为0.82±0.18;实质对比噪声比分别为2.90±1.01和2.54±0.76(均p<0.01)。在延迟期,肝脏相对强化分别为1.17±0.41和0.61±0.19;实质对比噪声比分别为1.84±0.90和1.61±0.67(p<0.05)。在77 keV下,肝脏相对强化和实质对比噪声比与单能CT相似。在31个LI-RADS 5肿瘤(17例患者)中,50 keV双能CT的定量肿瘤强化和肿瘤对比噪声比在所有期相均显著高于单能CT,包括门静脉期(-29.48±16.4 vs. -13.38±11.98,p<0.001)和延迟期(-23.48±13.43 vs. -8.14±10.49,p<0.001)。

临床应用与阅片要点

  • 作者结论支持在肝硬化患者中使用50 keV双能CT虚拟单能图像,以在降低碘对比剂剂量的同时改善肝脏和肿瘤对比。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To compare liver parenchymal enhancement and tumor washout on portal and delayed phases between rapid kVp-switching dual-energy CT (DECT) with a low-iodine-dose (LID) contrast medium protocol (350 mg/kg) and conventional single-energy CT (SECT) with a standard-iodine-dose protocol (525 mg/kg), in patients referred for primary liver cancer.

MATERIALS AND METHODS: All consecutive patients referred for primary liver cancer assessment who underwent both SECT with standard iodine dose and DECT with LID protocol were retrospectively reviewed. Relative Liver Enhancement (RLE) and parenchymal contrast-to-noise ratio (pCNR) on portal venous (PVP) and delayed phases were compared between 50 keV virtual monochromatic DECT and SECT images. A sub-analysis at 77 keV was also performed. Quantitative tumor enhancement (QTE) and tumoral contrast-to-noise ratio (tCNR) were compared between techniques in a subset of patients bearing LI-RADS 5 liver tumors.

RESULTS: Seventy-seven patients (mean age 66±9 years) were included and 154 CT scans were analyzed (February 2023-October 2023). RLE and pCNR were significantly higher on 50-keV DECT than on SECT during both PVP (RLE: 1.68 ± 0.45 vs. 0.82 ± 0.18; pCNR: 2.90 ± 1.01 vs. 2.54 ± 0.76; all p < 0.01) and delayed phases (RLE: 1.17 ± 0.41 vs. 0.61 ± 0.19; pCNR: 1.84 ± 0.90 vs. 1.61 ± 0.67; p < 0.05). At 77 keV, RLE and pCNR were similar to SECT. Among thirty-one LR-5 tumors (n = 17 patients), QTE and tCNR were significantly greater on 50-keV DECT than SECT across all phases including PVP (-29.48 ± 16.4 vs. -13.38 ± 11.98 p < 0.001) and delayed phase (-23.48 ± 13.43 vs. -8.14 ± 10.49 p < 0.001).

CONCLUSION: Rapid kVp-switching DECT at 50-keV DECT VMIs improves liver and tumor contrast on PVP and delayed phase despite a 33% iodine dose reduction, supporting its use in cirrhotic patients.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Bonnet B, Mulé S, Pigneur F, et al. Liver enhancement using rapid kVp-switching dual-energy CT with reduced iodine contrast dose compared with single-energy CT with standard iodine dose: an intra-patient comparison. Abdom Radiol (NY). 2025. PMID: 40673938. doi:10.1007/s00261-025-05114-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。